跳至主要内容
临床试验/NCT01550250
NCT01550250已完成不适用

Feasibility of Night-time Compression Systems for Breast Cancer Related Lymphedema: a Pilot Study

University of Alberta4 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
4
主要终点
Accrual rate

研究概览

简要总结

Women who have undergone breast cancer surgery may develop swelling of the arm on the side the breast cancer occurred. If the swelling becomes chronic it is called lymphedema. This study will examine night-time compression system garments for lymphedema. Our objective is to determine if breast cancer survivors are willing and able to use the garment overnight to help control their lymphedema. Thirty breast cancer survivors from Alberta will be enrolled in the 24-week long study. Measurements will be taken of each arm to assess the extent of lymphedema and to measure changes over the study period. We will also examine other outcomes such as the impact of the night-time compression system garment on sleep. The study will provide important information on the feasibility of night-time compression system garments as a self-management strategy for lymphedema.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with a histological diagnosis of breast cancer experiencing edema in the ipsilateral arm such that there is a minimum 10% and maximum 40% increase in arm volume over the unaffected arm (mild to moderate lymphedema).
  • Patients must have completed all primary and adjuvant treatments (surgery, chemotherapy, radiotherapy) prior to randomization.
  • Patients must have their own fitted compression garment for daytime maintenance.
  • No past or current use of a night-time compression system for maintenance. Those patients who have trialed a night-time compression system in the past year must observe a six-month washout period before entering the trial.

排除标准

  • Clinical or radiological evidence of active disease, either local or metastatic.
  • History of contralateral breast cancer and axillary surgery.
  • Serious non-malignant disease, such as renal or cardiac failure, which would preclude daily treatment and follow-up.
  • Patients for whom compression is contraindicated.
  • Psychiatric or addictive disorders which preclude obtaining informed consent or adherence to the protocol.
  • Unable to comply with the protocol, measurement and follow-up schedule.

结局指标

主要结局

Accrual rate

时间窗: 18 months

The number of women eligible for the study and number agreeing to participate.

次要结局

  • Adherence(24 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Night-time Compression Systems for Breast Cancer... | 临床试验